NO168770C - Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater

Info

Publication number
NO168770C
NO168770C NO873091A NO873091A NO168770C NO 168770 C NO168770 C NO 168770C NO 873091 A NO873091 A NO 873091A NO 873091 A NO873091 A NO 873091A NO 168770 C NO168770 C NO 168770C
Authority
NO
Norway
Prior art keywords
preparation
therapeutic active
analogy procedure
benzimidazold
derivatives
Prior art date
Application number
NO873091A
Other languages
English (en)
Norwegian (no)
Other versions
NO873091L (no
NO168770B (no
NO873091D0 (no
Inventor
Noriyoshi Sueda
Yoshikuni Suzuki
Toshiji Sugai
Hiroaki Yamada
Makoto Yanai
Original Assignee
Nisshin Flour Milling Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Flour Milling Co filed Critical Nisshin Flour Milling Co
Publication of NO873091D0 publication Critical patent/NO873091D0/no
Publication of NO873091L publication Critical patent/NO873091L/no
Publication of NO168770B publication Critical patent/NO168770B/no
Publication of NO168770C publication Critical patent/NO168770C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO873091A 1986-07-25 1987-07-23 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater NO168770C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17375986 1986-07-25
JP62171139A JPH0784462B2 (ja) 1986-07-25 1987-07-10 ベンゾイミダゾ−ル誘導体

Publications (4)

Publication Number Publication Date
NO873091D0 NO873091D0 (no) 1987-07-23
NO873091L NO873091L (no) 1988-01-26
NO168770B NO168770B (no) 1991-12-23
NO168770C true NO168770C (no) 1992-04-01

Family

ID=26493951

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873091A NO168770C (no) 1986-07-25 1987-07-23 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater

Country Status (10)

Country Link
US (1) US4886803A (fr)
EP (1) EP0254322B1 (fr)
JP (1) JPH0784462B2 (fr)
KR (1) KR960011388B1 (fr)
AU (1) AU597696B2 (fr)
CA (1) CA1305481C (fr)
DE (1) DE3781845T2 (fr)
ES (1) ES2044878T3 (fr)
FI (1) FI91152C (fr)
NO (1) NO168770C (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE58907869D1 (de) * 1988-03-21 1994-07-21 Ciba Geigy Mittel zum Schutz von Pflanzen gegen Krankheiten.
US5089592A (en) * 1988-06-09 1992-02-18 The Dow Chemical Company Biscyclobutarene monomer comprising two cyclobutarene moieties bridged by a divalent radical comprising at least one benzothiazole or benzimidazole linkage
IT1251144B (it) * 1991-07-30 1995-05-04 Boehringer Ingelheim Italia Derivati del benzimidazolone
EP0602586B1 (fr) * 1992-12-16 1997-06-04 Takeda Chemical Industries, Ltd. Composition pharmaçeutrique stable contenant des dérivés de tumagillol
US5637724A (en) * 1995-06-05 1997-06-10 Neurogen Corporation Substituted aryl and cycloalkyl imidazolones; a new class of GABA brain receptor ligands
US5637725A (en) * 1995-06-05 1997-06-10 Neurogen Corporation Substituted aryl and cycloalkyl imidazolones; a new class of GABA brain receptor ligands
TW381092B (en) * 1995-07-07 2000-02-01 Otsuka Pharma Co Ltd Novel benzimidazole derivatives for use in treating arteriosclerotic diseases
EP1263737A1 (fr) * 2000-02-09 2002-12-11 The Procter & Gamble Company 2-phenylcarbamoyl-benzimidazoles
US7183410B2 (en) * 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
US20030060475A1 (en) * 2001-08-10 2003-03-27 Boehringer Ingelheim Pharma Kg Method of using flibanserin for neuroprotection
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
FR2833494B1 (fr) * 2001-12-19 2006-12-15 Univ Nantes Utilisation de composes de la famille des benzamides comme agent immunosuppresseur
JP2005289816A (ja) * 2002-05-14 2005-10-20 Banyu Pharmaceut Co Ltd ベンズイミダゾール誘導体
US20050250814A1 (en) * 2002-10-30 2005-11-10 Cangyou Zhou Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
EP1479676A1 (fr) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH Dérivés de benzimidazole en tant qu'inhibiteurs du facteur Xa
US7741341B2 (en) 2003-05-19 2010-06-22 Sanofi-Aventis Deutschland Gmbh Benzimidazole-derivatives as factor Xa inhibitors
US20050239798A1 (en) * 2004-04-22 2005-10-27 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the treatment of premenstrual and other female sexual disorders
RU2445095C2 (ru) * 2004-04-22 2012-03-20 Бёрингер Ингельхайм Интернациональ Гмбх Новые фармацевтические композиции для лечения сексуальных расстройств
AU2005324492B2 (en) * 2004-04-23 2012-06-07 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
US20060025420A1 (en) * 2004-07-30 2006-02-02 Boehringer Ingelheimn International GmbH Pharmaceutical compositions for the treatment of female sexual disorders
CA2576812A1 (fr) * 2004-09-03 2006-03-09 Boehringer Ingelheim International Gmbh Methode de traitement du trouble de l'hyperactivite avec deficit de l'attention
US20060199805A1 (en) * 2005-03-04 2006-09-07 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
WO2006096439A2 (fr) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Compositions pharmaceutiques destinees au traitement et/ou a la prevention de la schizophrenie et de maladies associees
EP1858516A1 (fr) * 2005-03-04 2007-11-28 Boehringer Ingelheim International GmbH Compositions pharmaceutiques utiles dans le traitement et/ou la prevention de la depression
EP1904182A2 (fr) * 2005-05-06 2008-04-02 Boehringer Ingelheim International GmbH Methode de traitement de la toxicomanie avec flibanserine
EP1888071A1 (fr) * 2005-05-19 2008-02-20 Boehringer Ingelheim International GmbH Procede pour le traitement de dysfonctionnements sexuels d origine medicamenteuse
EP1888070A1 (fr) * 2005-05-19 2008-02-20 Boehringer Ingelheim International GmbH Procede pour le traitement de dysfonctionnements sexuels dus a des etats pathologiques
US8227476B2 (en) 2005-08-03 2012-07-24 Sprout Pharmaceuticals, Inc. Use of flibanserin in the treatment of obesity
EP2407459A1 (fr) 2005-09-27 2012-01-18 Shionogi & Co., Ltd. Intermédiaire synthétique dans la production d'un dérivé sulfonamide ayant une activité antagoniste de récepteur PGD2
US20070123540A1 (en) * 2005-10-29 2007-05-31 Angelo Ceci Sexual desire enhancing medicaments comprising benzimidazolone derivatives
US7923449B2 (en) * 2005-10-29 2011-04-12 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
US20070105869A1 (en) * 2005-11-08 2007-05-10 Stephane Pollentier Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
AU2007247094B2 (en) * 2006-05-09 2012-11-01 Sprout Pharmaceuticals, Inc. Use of flibanserin for the treatment of post-menopausal Sexual Desire Disorders
CA2654798C (fr) 2006-06-30 2015-01-13 Boehringer Ingelheim International Gmbh Flibanserine dans le traitement de l'incontinence urinaire et des maladies associees
EP2043648A1 (fr) * 2006-07-14 2009-04-08 Boehringer Ingelheim International GmbH Utilisation de flibansérine pour le traitement de troubles sexuels chez les femmes
AU2007286288A1 (en) * 2006-08-14 2008-02-21 Boehringer Ingelheim International Gmbh Formulations of flibanserin and method for manufacturing the same
CL2007002214A1 (es) * 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
WO2008022932A2 (fr) * 2006-08-25 2008-02-28 Boehringer Ingelheim International Gmbh Système de libération contrôlée et procédé de préparation correspondant
ES2627221T3 (es) 2006-12-28 2017-07-27 Rigel Pharmaceuticals, Inc. Compuestos de heterocicloalquiloxibenzamida N-sustituidos y métodos de uso
UY31335A1 (es) 2007-09-12 2009-04-30 Tratamiento de sintomas vasomotores
WO2011026917A1 (fr) * 2009-09-04 2011-03-10 Novartis Ag Composés d'hétéroaryle en tant qu'inhibiteurs de kinase
US8518948B2 (en) 2010-03-10 2013-08-27 Ingenium Pharmaceuticals Gmbh Inhibitors of protein kinases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4634704A (en) * 1983-10-06 1987-01-06 Janssen Pharmaceutica, N.V. Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines

Also Published As

Publication number Publication date
NO873091L (no) 1988-01-26
FI873205A (fi) 1988-01-26
AU597696B2 (en) 1990-06-07
NO168770B (no) 1991-12-23
NO873091D0 (no) 1987-07-23
EP0254322B1 (fr) 1992-09-23
FI91152B (fi) 1994-02-15
DE3781845T2 (de) 1993-02-18
US4886803A (en) 1989-12-12
ES2044878T3 (es) 1994-01-16
FI873205A0 (fi) 1987-07-21
KR960011388B1 (ko) 1996-08-22
EP0254322A1 (fr) 1988-01-27
AU7596587A (en) 1988-01-28
DE3781845D1 (de) 1992-10-29
JPH0784462B2 (ja) 1995-09-13
JPS63146871A (ja) 1988-06-18
KR880001611A (ko) 1988-04-25
FI91152C (fi) 1994-05-25
CA1305481C (fr) 1992-07-21

Similar Documents

Publication Publication Date Title
NO168770C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO170629C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater
NO172801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO168174C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive triazolforbindelser
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO874032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO167026C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO167916C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater
NO168355C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO169438C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazolforbindelser
NO168299C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater
NO170976C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylbuten-syrederivater
NO172539C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser
NO169069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater
NO173185C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoxalinforbindelser
NO170582C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelser
NO173061C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner
NO169007C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive uridinderivater
NO172802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyraner
NO169648C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater
NO164895C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO168103C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aralkylimidazolderivater